Cargando…

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

BACKGROUND: Lung cancer (LC) is the leading cause of cancer-related deaths. Oxidative DNA damage may contribute to the cancer risk. The antioxidant paraoxonase (PON1) is an endogenous free radical scavenger in the human body. The aim of this study was to determine serum PON1 and arylesterase (ARE) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elkiran, Emin T, Mar, Nefsal, Aygen, Bilge, Gursu, Ferit, Karaoglu, Aziz, Koca, Suleyman
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839096/ https://www.ncbi.nlm.nih.gov/pubmed/17362500 http://dx.doi.org/10.1186/1471-2407-7-48

Ejemplares similares

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
por: Erdem, Fazile Hatipoglu, et al.
Publicado: (2010)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Serum Paraoxonase/Arylesterase Activity and Oxidative Stress Status in Children with Metabolic Syndrome
por: Eren, Erdal, et al.
Publicado: (2014)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
por: Gabaldó, Xavier, et al.
Publicado: (2022)

Paraoxonase and Arylesterase Activities in Dipper and Non-Dipper Prehypertensive Subjects
por: Yuksel, Murat, et al.
Publicado: (2015)

Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study
por: Meisinger, Christa, et al.
Publicado: (2021)

Serum Paraoxonase, Arylesterase, and Glutathione-S-Transferase Activities and Oxidative Stress Levels in Patients with Mushroom Poisoning
por: Eren, Sevki Hakan, et al.
Publicado: (2018)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
por: Schilcher, Irene, et al.
Publicado: (2021)

Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment
por: Güneş, Mehmet, et al.
Publicado: (2016)

Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis
por: Bassu, Stefania, et al.
Publicado: (2022)

Paraoxonase and Arylesterase Activities, Lipid Profile, and Oxidative Damage in Experimental Ischemic Colitis Model
por: Unal, Ethem, et al.
Publicado: (2012)

The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats
por: Takaeidi, Mohammad Reza, et al.
Publicado: (2014)

Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
por: Ayan, Durmuş, et al.
Publicado: (2019)

Total Oxidant Status, Total Antioxidant Status, and Paraoxonase and Arylesterase Activities during Laparoscopic Cholecystectomy
por: Koksal, Hande, et al.
Publicado: (2010)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
por: Asare, George Awuku, et al.
Publicado: (2018)

Vitamin B6 Supplementation Improves Oxidative Stress and Enhances Serum Paraoxonase/Arylesterase Activities in Streptozotocin-Induced Diabetic Rats
por: Taş, Sibel, et al.
Publicado: (2014)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2022)

Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum
por: Aoki, Yutaka, et al.
Publicado: (2014)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders
por: Piras, Ignazio Stefano, et al.
Publicado: (2021)

Relationship between Paraoxonase-1 and Arylesterase Enzyme Activities and SYNTAX I and II Scores in Patients with ST-Elevation Myocardial Infarction
por: Sökmen, Erdoğan, et al.
Publicado: (2019)

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
por: Reisinger, Alexander C., et al.
Publicado: (2020)

Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population
por: Özbey, Ulku, et al.
Publicado: (2011)

Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet
por: de la Iglesia, Rocio, et al.
Publicado: (2014)

Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)
por: Ozaslan, Ersin, et al.
Publicado: (2018)

Total Serum Oxidant/Antioxidant Status and Arylesterase Activity in Recurrent Aphthous Stomatitis
por: Akoglu, Gulsen, et al.
Publicado: (2013)

Arylesterase activity of paraoxonase 1 (PON1) on HDL(3) and HDL(2): Relationship with Q192R, C-108T, and L55M polymorphisms
por: Valencia C, Sandra Y., et al.
Publicado: (2021)

Mining bacterial genomes for novel arylesterase activity
por: Wang, Lijun, et al.
Publicado: (2010)

Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population
por: Benekli, Mustafa, et al.
Publicado: (2014)

Low Paraoxonase 1 Arylesterase Activity and High von Willebrand Factor Levels are Associated with Severe Coronary Atherosclerosis in Patients with Non-Diabetic Stable Coronary Artery Disease
por: Ding, Jieying, et al.
Publicado: (2014)

Vitamin-D Binding Protein Gene Polymorphisms and Serum 25-Hydroxyvitamin-D in a Turkish Population
por: Karcıoğlu Batur, Lutfiye, et al.
Publicado: (2021)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
por: Idrees, Muhammad, et al.
Publicado: (2018)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Erratum: Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
Publicado: (2019)

Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
por: Agilli, Mehmet, et al.
Publicado: (2014)

Serum Paraoxonase as an Indicator for Fatty Liver in Sheep
por: Cao, Yu, et al.
Publicado: (2017)

Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1
por: Blaha-Nelson, David, et al.
Publicado: (2016)

The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
por: Moshtaghie, Elham, et al.
Publicado: (2022)

The association of paraoxonase 1 gene L55M polymorphism with the extent and severity of coronary artery disease in the Turkish population and its dependence on gender
por: Kocakap, Derya Beyza Sayın, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_phg2gltfp47jjslc27apf38fql